Patents by Inventor MOHAMMAD SHAHIDUL ISLAM

MOHAMMAD SHAHIDUL ISLAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11944604
    Abstract: A spirooxindole nanoformulation includes a proniosome loaded with a spirooxindole derivative.
    Type: Grant
    Filed: March 10, 2023
    Date of Patent: April 2, 2024
    Assignee: KING SAUD UNIVERSITY
    Inventors: Assem Barakat, Fardous F. El-Senduny, Mohammad Shahidul Islam, Abdullah Mohammed Al Majid, Yaseen Ali Mosa Mohamed Elshaier, Eman Ahmed Ibrahim Mazyed, Farid A. Badria
  • Patent number: 10440032
    Abstract: A method of a second terminal for sharing a use authority of a service allowed by a first user of a first terminal is provided. The method includes requesting an authorization server for authentication information of the service, wherein the authorization server stores identification information of a second user with whom the use authority is sharable and a validity period during which the use authority is shared with the second user, when a user of the second terminal corresponds to the second user, receiving the authentication information from the authorization server, and, receiving the use authority of the service during the validity period.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: October 8, 2019
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Mohammad Shahidul Islam, Redwan Ui Haq Choyon
  • Patent number: 9822128
    Abstract: The substituted spirooxindoles are MDM2-p53 inhibitors bearing a benzylidine (styryl) arm and have a complex fused ring system ideally suited for binding to the MDM2 protein, thereby interrupting its protein-protein interaction (PPI). Sixteen compounds, designated 4a-4p, were synthesized in a simple smooth method using an asymmetric 1,3-dipolar reaction as the key step. Testing showed that the compounds exhibit anti-cancer activity against various forms of cancer cells affecting humans.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: November 21, 2017
    Inventors: Assem Barakat, Mohammad Shahidul Islam, Abdullah Mohammed Al Majid, Hussain Mansur Ghawas, Fardous F. El-Senduny, Farid A. Badria, Yaseen Ali Mosa Mohamed Elshaier, Hazem A. Ghabbour
  • Patent number: 9802894
    Abstract: Novel ?-Glucosidase inhibitors include propanone substituted indole ring-containing heterocyclic compounds, which are represented by Formula I: Wherein R1 is thiophene, 2,4-di chloro phenyl, 2,6-di chloro phenyl, bromo phenyl, benzyl or nitrophenyl; and R2 is an aryl group, or stereoisomers or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: October 31, 2017
    Assignee: KING SAUD UNIVERSITY
    Inventors: Abdullah Mohammed Al-Majid, Mohammad Shahidul Islam, Assem Barakat, Muhammad Iqbal Choudhary, Sammer Yousuf
  • Publication number: 20170134393
    Abstract: A method of a second terminal for sharing a use authority of a service allowed by a first user of a first terminal is provided. The method includes requesting an authorization server for authentication information of the service, wherein the authorization server stores identification information of a second user with whom the use authority is sharable and a validity period during which the use authority is shared with the second user, when a user of the second terminal corresponds to the second user, receiving the authentication information from the authorization server, and, receiving the use authority of the service during the validity period.
    Type: Application
    Filed: September 29, 2016
    Publication date: May 11, 2017
    Inventors: Mohammad Shahidul ISLAM, Redwan Ul Haq CHOYON
  • Publication number: 20170088516
    Abstract: Novel ?-Glucosidase inhibitors include propanone substituted indole ring-containing heterocyclic compounds, which are represented by Formula I: Wherein R1 is thiophene, 2,4-di chloro phenyl, 2,6-di chloro phenyl, bromo phenyl, benzyl or nitrophenyl; and R2 is an aryl group, or stereoisomers or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 29, 2015
    Publication date: March 30, 2017
    Inventors: ABDULLAH MOHAMMED AL-MAJID, MOHAMMAD SHAHIDUL ISLAM, ASSEM BARAKAT, MUHAMMAD IQBAL CHOUDHARY, SAMMER YOUSUF